COMP <GO>
CLX vs TSLA // EV/EBITDA & P/E VALUATION
Clorox Company (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: CLX 8
— TSLA 5
▲ EV/EBITDA & P/E VALUATION LEADER: CLX
LAST: $88.67 (+2.11%) • MKT CAP: $10.72B
valuation
10.9x
LAST: $403.30 (-0.23%) • MKT CAP: $1.59T
valuation
199.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLX VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLX | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.20% | 19.29% | +25.91 | CLX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.20% | 3.39% | +33.81 | CLX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.9x | 199.0x | -188.14 | CLX | /valuation <GO> |
| Free Cash Flow Yield | 7.10% | 0.21% | +6.89 | CLX | /fcf-yield <GO> |
| Operating Margin | 14.20% | 3.35% | +10.85 | CLX | /operating-margins <GO> |
| Net Profit Margin | 11.60% | 3.11% | +8.49 | CLX | /net-margins <GO> |
| Revenue Growth (YoY) | 0.20% | 8.30% | -8.10 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.61% | 0.00% | +5.61 | CLX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 15.35 | -12.42 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | CLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 8.72% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 56.6 | -1.00 | TSLA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 1.89 | -0.96 | TSLA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.1x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.72B | $1.59T | -$1.58T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLX REV | TSLA REV | CLX GROSS % | TSLA GROSS % | CLX FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.10B | $94.83B | 45.2% | 18.0% | $761.0M | $6.22B |
| FY 2024 | $7.09B | $97.69B | 43.0% | 17.9% | $483.0M | $3.58B |
| FY 2023 | $7.39B | $96.77B | — | 18.3% | $825.5M | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLX // BETA 0.93
TSLA // BETA 1.89